Atlas Trials

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Clinical trial NCT00503035 · COMPLETED

Trial details

NCT number
NCT00503035
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Familial Adenomatous Polyposis
Start date
2003-08-20
Primary completion
2021-04-02
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.